Novocure's device shown to slow cancer progression in the brain in trial

Go back to Novocure's device shown to slow cancer progression in the brain in trial
(NASDAQ: NVCR) Delayed: 12.90 -0.21 (1.6%)
Previous Close $13.11    52 Week High $28.95 
Open $12.81    52 Week Low $5.95 
Day High $13.00    P/E N/A 
Day Low $12.52    EPS $0.00 
Volume 262,738